G Holló - Expert Opin. Drug Saf., 2007 - informahealthcare.com In the last decade topically applied prostaglandin F2α analogues (bimatoprost, latanoprost, travoprost
and unoprostone) have become widely used as a means to reduce elevated intraocular pressure
in patients with glaucoma and ocular hypertension. These molecules all have similar side- ... Cited by 19 - Related articles - BL Direct - All 7 versions
- ►oculist.net [PDF] TW HEJKAL, CB CAMRAS - Glaucoma Medical Therapy: Principles …, 2007 - books.google.com Prostaglandin Analogs THOMAS W. HEJKAL AND CARL B. CAMRAS Prostaglandin (PG)
analogs, originally introduced for glaucoma therapy in the United States with latanoprost in
1996, have rapidly become the most commonly used ocular hypotensive agents. As a ... Cited by 5 - Related articles - BL Direct - All 3 versions
S Dunker, A Schmucker, H Maier - Advances in therapy, 2007 - Springer This study was undertaken to assess tolerability, quality of life, and persistency of use and to
monitor changes in intraocular pressure (IOP) during the first 6 mo after a switch to fixed combination
latanoprost/timolol. In Germany, 271 general oph- thalmology practices enrolled patients ... Cited by 3 - Related articles - BL Direct - All 3 versions
MN Lazaridou, DMI Montgomery, W Onn … - Current Medical …, 2008 - informahealthcare.com Methods: The glaucoma database of the Glasgow Royal Infirmary was reviewed retrospectively
to identify patients ≥ 18 years of age with primary open-angle glaucoma or ocular hypertension
in at least one eye who had been switched to LTFC from a previous monotherapy or ... Cited by 2 - Related articles - All 6 versions
JM Vinuesa-Silva, I Vinuesa-Silva, MD Pinazo- … - Archivos de la Sociedad …, 2009 - SciELO Brasil SciELO - Scientific Electronic Library Online Browse SciELO, SciELO Library Error Detector An
unexpected error occurred in SciELO servers. Click on the SciELO logo to browse the SciELO
Library or use the browser "BACK" button to return to the previous page. ... Related articles - Cached - All 5 versions
S Sonty, JC Henry, E Sharpe, M Weiss, J … - Acta …, 2008 - interscience.wiley.com Methods: We carried out a prospective, open-label cohort study with an active-historical control
in which qualifying patients must have been treated with latanoprost monotherapy for at least
4 weeks, must have demonstrated insufficiently controlled intraocular pressure (IOP) (≥ ... Related articles - BL Direct - All 2 versions
GCM Rossi, GM Pasinetti, M Bracchino, M … - Expert Opin. …, 2009 - informahealthcare.com Purpose: To assess the usefulness and tolerability of systematically switching glaucoma patients
from latanoprost 0.005% and timolol 0.5% (Lat + Tim) to a fixed combination of travoprost
0.004%/timolol 0.5% (TTFC), and to record the effects of this switch on tear-film break-up ... Related articles - All 5 versions
M Ishikawa, T Yoshitomi - 2009 - pubmedcentral.nih.gov We studied 30 eyes from 30 POAG patients previously treated with latanoprost
monotherapy. After a washout of four weeks in both eyes, all patients were treated with 0.5%
timolol and latanoprost. Three months after the initiation of treatment with timolol and ... Related articles - All 4 versions
JM Vinuesa-Silva, I Vinuesa-Silva, MD Pinazo- … - Archivos de la Sociedad …, 2009 - oftalmo.com Objetivo Valorar la asociación de hiperemia conjuntival con el uso de la combinación fija de
latanoprost/timolol en el tratamiento del glaucoma, a través de una revisión sistemática y de
un metaanálisis. Métodos Se efectuó una búsqueda de los ensayos clínicos publicados ... Related articles - Cached - All 4 versions
S BAKANLIĞI, HNEVEA HASTANESİ, І KLİNİĞİ - istanbulsaglik.gov.tr Page 1. 1 TC SAĞLIK BAKANLIĞI HAYDARPAŞA NUMUNE EĞİTİM VE ARAŞTIRMA
HASTANESİ І. GÖZ KLİNİĞİ Klinik Şefi: Doç. Dr. Ahmet Fazıl NOHUTCU PRİMER AÇIK AÇILI
GLOKOMLU HASTALARDA LATANOPROST % 0.005 VE TİMOLOL MALEAT ... Related articles - View as HTML